/PRNewswire/ Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today.
/PRNewswire/ Sixty-five percent of people ages 18 years and older with hearing, speech, and/or language disorders say that they encounter stigmas, according.
/PRNewswire/ Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage precision oncology company focused on developing and commercializing therapies for.